Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor of Peripheral Nerve”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00790400
What this trial is testing

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

Who this might be right for
Tuberous Sclerosis Complex (TSC)Lymphangioleiomyomatosis (LAM)
Novartis Pharmaceuticals 118
Testing effectiveness (Phase 2)Looking for participantsNCT06607692
What this trial is testing

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

Who this might be right for
Solid Tumor CancerMedulloblastomaHigh Risk Neuroblastoma+19 more
Fundación de investigación HM 25
Testing effectiveness (Phase 2)Looking for participantsNCT07537400
What this trial is testing

Patients Between the Ages of 12 Months to 21 Years With Newly-Diagnosed High-Risk Neuroblastoma Will Receive Children's Oncology Group (COG) Type Recommended Therapy With the Addition of Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) to Induction Cycles 1-5

Who this might be right for
High-Risk Neuroblastoma
Shaare Zedek Medical Center 10
Not applicableStudy completedNCT03666507
What this trial is testing

Vegetative Monitoring During Brainstem-associated Surgery

Who this might be right for
Brain Tumor, RecurrentVestibular SchwannomaBrainstem Neoplasm+1 more
University Hospital Tuebingen 103
Early research (Phase 1)Study completedNCT02211768
What this trial is testing

Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1

Who this might be right for
NeurofibromatosisMPNST
National Cancer Institute (NCI) 10
Large-scale testing (Phase 3)Study completedNCT00423618
What this trial is testing

Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Sheffield Teaching Hospitals NHS Foundation Trust 216
Testing effectiveness (Phase 2)Ended earlyNCT00617890
What this trial is testing

Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing's Sarcoma (MK-7454-002/P04720)

Who this might be right for
OsteosarcomaSarcoma, Ewing'sPeripheral Neuroectodermal Tumor
Merck Sharp & Dohme LLC 219
Testing effectiveness (Phase 2)Study completedNCT00276679
What this trial is testing

Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Cancer and Leukaemia Group
Not applicableEnded earlyNCT02584413
What this trial is testing

Hypotonia and Neurofibromatosis Type 1 (NF1) Glioma

Who this might be right for
Neurofibromatosis Type 1
Washington University School of Medicine 29
Not applicableStudy completedNCT00618813
What this trial is testing

Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors

Who this might be right for
Ewing Sarcoma of BoneLocalized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
Children's Oncology Group 35
Testing effectiveness (Phase 2)Study completedNCT00130962
What this trial is testing

ALGRX 4975 in the Treatment of Patients With Morton's Neuroma

Who this might be right for
Neuroma
AlgoRx Pharmaceuticals 60
Early research (Phase 1)Active Not RecruitingNCT03478462
What this trial is testing

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

Who this might be right for
Pediatric Solid TumorPediatric LymphomaPediatric Brain Tumor+5 more
Cellectar Biosciences, Inc. 30
Testing effectiveness (Phase 2)WithdrawnNCT06233903
What this trial is testing

18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System

Who this might be right for
NeuroblastomaPheochromocytomaParaganglioma
Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)
Not applicableStudy completedNCT00684398
What this trial is testing

Adaptation and Quality of Life Among Adults With Neurofibromatosis Type I

Who this might be right for
Neurofibromatosis Type 1Von Recklinghausen DiseaseNF1
National Human Genome Research Institute (NHGRI) 645
Testing effectiveness (Phase 2)Study completedNCT01125800
What this trial is testing

A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB

Who this might be right for
MedulloblastomaRhabdomyosarcomaNeuroblastoma+3 more
Novartis Pharmaceuticals 76
Not applicableStudy completedNCT00624234
What this trial is testing

Neurobiology and Treatment of Reading Disability in NF-1

Who this might be right for
Neurofibromatosis Type 1Reading Disabilities
Vanderbilt University 184
Testing effectiveness (Phase 2)Looking for participantsNCT01804634
What this trial is testing

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Who this might be right for
Refractory and/or Relapsed Metastatic Solid Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07521657
What this trial is testing

Efficacy of Mirdametinib Alone or Combination With Radiotherapy for Germline and Sporadic NF1-Altered High-Grade Glioma

Who this might be right for
Neurofibromatosis 1 (NF1)
University of Alabama at Birmingham 55
Early research (Phase 1)Study completedNCT06132165
What this trial is testing

Efficacy of Skin Cooling in Reducing Pain Associated With Non-invasive Treatments of Neurofibromatosis Type 1 Cutaneous Neurofibromas

Who this might be right for
Neurofibromatosis 1
Massachusetts General Hospital 13
Not applicableStudy completedNCT01135875
What this trial is testing

Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients

Who this might be right for
Glioblastoma MultiformeHealthy Volunteers
University of Florida 130
Next Page